Companies / Vor Biopharma Inc.
Vor Biopharma Inc.
Nasdaq: VORCIK 1817229BOSTON, MA
Financials
Ownership
59.2M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 4.06% | 2,402,095 |
| 10%+ / strategic | 13.32% | 7,880,103 |
| Institutions | 39.72% | 23,500,648 |
| Public float | 42.90% | 25,379,448 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
RA Capital Management, L.P.Director · 10% owner | 4.06% | 2,402,095 |
Kolchinsky PeterDirector · 10% owner | — | — |
RA Capital Healthcare Fund LPDirector · 10% owner | — | — |
Shah Rajeev M.Director · 10% owner | — | — |
Institutional holders 63
View all →| Holder | Value | % of shares |
|---|---|---|
| $96.43M | 9.14% | |
| $63.85M | 5.86% | |
| $48.17M | 4.42% | |
| $47.31M | 6.11% | |
| $33.27M | 4.30% | |
| $33.04M | 4.27% | |
| $31.22M | 2.96% | |
| $25.42M | 3.29% | |
| $22.89M | 2.96% | |
| $20.57M | 1.95% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $8.88M | -538K -10.45% | 4,607,244 7.79% of shares | medium |
| Apr 13, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $8.57M | -531K -13.48% | 3,404,998 5.76% of shares | medium |
| Apr 17, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $7.46M | -458K -14.34% | 2,739,208 4.63% of shares | medium |
| Apr 8, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $5.76M | -353K -7.75% | 4,202,499 7.10% of shares | medium |
| Apr 2, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $4.71M | -258K -4.78% | 5,146,523 8.70% of shares | medium |
| Apr 20, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $2.71M | -172K -6.28% | 2,567,245 4.34% of shares | medium |
| Apr 22, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $2.60M | -165K -6.43% | 2,402,095 4.06% of shares | medium |
| Apr 14, 2026 | RA Capital Management, L.P. Director | Sell | Common Stock | $2.46M | -154K -4.52% | 3,251,263 5.50% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Fmr LLC | Passive13G/A | — |
| Great Point Partners, LLC | Passive13G/A | — |
| Venrock Healthcare Capital Partners III, L.P. | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Qiming Venture Partners VIII-HC, L.P. | Passive13G/A | — |
| Paradigm BioCapital Advisors LP | Passive13G/A | — |
| Verve Capital Limited | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VOR | — | 929033207 |